Fortress Biotech Inc - Company Profile
Powered by
All the data and insights you need on Fortress Biotech Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Fortress Biotech Inc Strategy Report
- Understand Fortress Biotech Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Fortress Biotech Inc patents, including inventor and filing insights.
Patent Trends
Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
---|---|---|---|---|
US20240150468A1 | Application | Pd-l1-specific antibodies and methods of using the same | C07K16/30; C07K2317/567; C07K16/2827; A61K45/06; C07K2317/732; C07K2317/56; C07K2317/92; A61K39/3955; A61P35/00; C07K2317/76; C07K2317/565 | May 09, 2024 |
US20240139236A1 | Application | Copper histidinate compositions and uses thereof | A61K31/4172; A61K33/34; A61K9/0019; A61K9/19; A61P3/02 | May 02, 2024 |
EP3842419B1 | Grant | Verfahren zur herstellung von threo glycopyrrolat-tosylat | A61K47/10; A61K47/32; A61K9/0014; A61K9/08; C07B2200/13; A61K9/70; A61K31/40; A61K47/12; A61P43/00; A61P17/00; A61K47/34; C07D207/12 | April 03, 2024 |
EP4308104A1 | Application | Kupferhistidinatzusammensetzungen und verwendungen davon | A61K31/30; A61K31/555; A61K9/0009; A61K9/0019; A61K9/19; A61P25/00 | January 24, 2024 |
US11834505B2 | Grant | Pd-l1-specific antibodies and methods of using the same | C07K2317/92; A61K39/3955; C07K2317/732; A61P35/00; C07K2317/76; C07K2317/567; C07K16/2827; C07K16/30; C07K2317/56; A61K45/06; C07K2317/565 | December 05, 2023 |
Top Inventors by Filings (Count by publication)
Name | Count |
---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer